These findings establish that hypertension-induced erectile dysfunction involves an ET-1/membrane depolarization/NLRP3 inflammasome axis in corpus cavernosum endothelial cells, and that targeting endothelial K<sub>Ca</sub> 2.2/2.3 channels represents a promising therapeutic strategy to counteract erectile dysfunction. Here, NLRP3 is linked to Hypertension.